-
-
Call more information
660-596-2224 -
ASA Monitor February 2024, Vol. 88, 16. Vaccine approval for chikungunya virus The U.S. Food and Drug Administration (FDA) has granted approval to Ixchiq, marking the first vaccine for chikungunya virus. Designed for individuals aged 18 and older at an elevated risk of chikungunya virus exposure, the vaccine addresses an emerging global health threat with over […]
Read MoreAuthor: Thomas H. Locke, MD, MPH ASA Monitor February 2024, Vol. 88, 19–21. Tribal nations have a unique relationship with the U.S. government, having ceded vast stretches of land and resources in exchange for specific treaty rights, one of which is health care services. The history of how this treaty obligation has been honored by the […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review Many physicians have experienced challenges stemming from Stark law, which bans them from making referrals for Medicare-payable health services if the physician or immediate family member has a financial relationship with the entity. Here are 10 key considerations to know: 1. Congress added an Anti-Kickback Statute to the Social […]
Read MoreNot about anesthesia but I wanted to share this with our readers. Author: Marty Stempniak InnovateHealthcare Radiology Business Breast cancer incidence is rising among U.S. women under 50, according to new research published in JAMA Network Open [1]. This includes elevated diagnosis rates for non-Hispanic Black women in their 20s and 30s, before the disease is even […]
Read MoreAuthors: Amr E. Abouleish, MD, MBA, FASA. et al ASA Monitor February 2024, Vol. 88, 15. At the 2023 ASA annual meeting, the House of Delegates approved an ASA statement titled “Statement on Fundamentals of a Safe and Healthy Workplace for Anesthesiologists.” Unlike traditional ASA declarations, this unique statement doesn’t introduce new policies, but rather consolidates existing […]
Read More